AFP and hepatocellular carcinoma: In a blind test, AFP had a better area under the receiver operating characteristic (ROC) curve than Des-gamma carboxy-prothrombin (DCP) and AFP-L3 in a total of 836 patients with chronic liver diseases and HCC [13].